Kyriakou Andreas, Dessens Arianne, Bryce Jillian, Iotova Violeta, Juul Anders, Krawczynski Maciej, Nordenskjöld Agneta, Rozas Marta, Sanders Caroline, Hiort Olaf, Ahmed S Faisal
Developmental Endocrinology Research Group, School of Medicine, University of Glasgow, Zone 1, Office Block, RHC & QEUH Campus, 1345 Govan Road, Glasgow, G51 4TF, UK.
Department of Child and Adolescent Psychiatry, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
Orphanet J Rare Dis. 2016 Nov 21;11(1):155. doi: 10.1186/s13023-016-0534-8.
To explore the current models of practice in centres delivering specialist care for children with disorders of sex development (DSD), an international survey of 124 clinicians, identified through DSDnet and the I-DSD Registry, was performed in the last quarter of 2014.
A total of 78 (63 %) clinicians, in 75 centres, from 38 countries responded to the survey. A formal national network for managing DSD was reported to exist in 12 (32 %) countries. The paediatric specialists routinely involved in the initial evaluation of a newborn included: endocrinologist (99 %), surgeon/urologist (95 %), radiologist (93 %), neonatologist (91 %), clinical geneticist (81 %) and clinical psychologist (69 %). A team consisting of paediatric specialists in endocrinology, surgery/urology, clinical psychology, and nursing was only possible in 31 (41 %) centres. Of the 75 centres, 26 (35 %) kept only a local DSD registry and 40 (53 %) shared their data in a multicentre DSD registry. Attendance in local, national and international DSD-related educational programs was reported by 69, 78 and 84 % clinicians, respectively. Participation in audits/quality improvement exercises in DSD care was reported by 14 (19 %) centres. In addition to complex biochemistry and molecular genetic investigations, 40 clinicians (51 %) also had access to next generation sequencing. A genetic test was reported to be more preferable than biochemical tests for diagnosing 5-alpha reductase deficiency and 17-beta hydroxysteroid dehydrogenase 3 deficiency by 50 and 55 % clinicians, respectively.
DSD centres report a high level of interaction at an international level, have access to specialist staff and are increasingly relying on molecular genetics for routine diagnostics. The quality of care provided by these centres locally requires further exploration.
为探究为性发育障碍(DSD)患儿提供专科护理的中心当前的实践模式,2014年最后一个季度对通过DSDnet和国际DSD注册机构确定的124名临床医生进行了一项国际调查。
来自38个国家75个中心的78名(63%)临床医生回复了调查。据报告,12个(32%)国家存在管理DSD的正式国家网络。常规参与新生儿初始评估的儿科专科医生包括:内分泌学家(99%)、外科医生/泌尿科医生(95%)、放射科医生(93%)、新生儿科医生(91%)、临床遗传学家(81%)和临床心理学家(69%)。只有31个(41%)中心能够组建由内分泌学、外科/泌尿科、临床心理学和护理方面的儿科专科医生组成的团队。在75个中心中,26个(35%)仅保留本地DSD注册信息,40个(53%)在多中心DSD注册机构中共享数据。分别有69%、78%和84%的临床医生报告参加了本地、国家和国际DSD相关教育项目。14个(19%)中心报告参与了DSD护理的审核/质量改进活动。除了复杂的生物化学和分子遗传学研究外,40名临床医生(51%)还可进行下一代测序。分别有50%和55%的临床医生报告,对于诊断5α还原酶缺乏症和17β羟类固醇脱氢酶3缺乏症,基因检测比生化检测更可取。
DSD中心报告称在国际层面有高度互动,能够获得专科医护人员,并且越来越依赖分子遗传学进行常规诊断。这些中心在本地提供的护理质量需要进一步探究。